{
  "doc_id": "BLS M1_Allergic ReactionAnaphylaxis BLS_March 2020",
  "file_path": "C:\\Users\\SAHARA\\OneDrive\\Desktop\\uni\\gemma\\risk_score\\rag_store\\sop_pdfs\\BLS M1_Allergic ReactionAnaphylaxis BLS_March 2020.pdf",
  "pages": [
    {
      "page_num": 1,
      "text": "March 2020 County of Marin EMS BLS M1\nALLERGIC REACTION/\nANAPHYLAXIS BLS\nIndications\n• Patients experiencing anaphylactic reaction and/or severe asthma. The following symptoms may\nbe present:\n• Stridor • Bronchospasm/wheezing/diminished breath sounds\n• Severe abdominal pain • Edema of the tongue, lips, face\n• Tachycardia • Generalized urticaria/hives\n• Shock (SBP <100) • Respiratory distress (nasal flaring or grunting in pediatric patients)\n• BLS RMC\n• Remove allergens\n• Verify need for EpiPen or Check & Inject Epinephrine\n®\n• See BLS PR 4A for Check & Inject Epinephrine procedure\n• Advise patient to self-administer EpiPen (or\n®\nequivalent) or administer appropriate EpiPen\n®\n• Adult Auto-Injector 0.3mg/0.3ml IM\n(weight >30 kg/66 lbs)\n• Pediatric Auto-Injector 0.15mg/0.15ml IM\n(weight <30 kg/66 lbs\nRecord time of injection and reassess in 2 minutes\n•\nMonitor airway and be prepared to\nassist with ventilations if necessary\nIf patient’s condition does\nnot improve in 5 minutes\n☎\n• PHYSICIAN CONSULT for\nSPECIAL CONSIDERATION second EpiPen ® injection\n• Elderly patients with signs\nof anaphylaxis and history\nof hypertension or heart\n• Monitor for response/side effects\ndisease should still be\n• Document assessment, VS every 5\ngiven epinephrine with\nmin, and medication dosage\ncaution. If concerned,\n• Transfer care to ALS personnel as\n☎\nPHYSICIAN CONSULT\nsoon as possible",
      "image_path": null
    }
  ]
}